• GSK Announces Third Acquisition of the Year 

    GSK announced on February 24 its third acquisition of 2026 with the purchase of 35Pharma Inc., a clinical-stage biopharmaceutical company. The purchase price is $950 million CAD (approximately $693 million USD).  Based in Montreal, Canada, 35Pharma develops novel transforming growth factor-beta superfamily therapeutics. 35Pharma’s lead... Read More »
  • Maxx Orthopedics Acquires TracPatch 

    On February 27, Maxx Orthopedics Inc. reported that it entered into an agreement to acquire TracPatch from Granger Group.   TracPatch is a non-invasive, FDA Class I exempt medical device that provides a digital health solution designed to provide accessible, connected and more predictable recovery. It provides surface-sensor, remote... Read More »
  • Heartland Dental Acquires Dentalogy 

    With the recent acquisition of Dentalogy, Heartland Dental has now reported three transactions in 2026. Since the start of 2025, Heartland Dental has reported 30 acquisitions.   Dentalogy is based out of one location in Irving, Texas. According to its website, the dental practice is run by Dr. Majid Sehat, who is the only physician on... Read More »
  • QC Capital Announces Strategic Investment in My Pediatric Doctor

    Charlotte, North Carolina-based QC Capital Group has made a strategic investment in My Pediatric Doctor, adding the company to its portfolio. Financial terms of the deal were not disclosed. My Pediatric Doctor is a 24/7 acute urgent care pediatric-focused telemedicine platform delivering virtual healthcare to children in all 50 states, along with... Read More »
  • Dovida Enters U.S. Market With A Place At Home Deal

    Dovida has entered the United States with the acquisition of A Place At Home, according to a February 25 press release. The acquisition marks Dovida’s expansion into its seventh market and its first in North America. Based in Omaha, Nebraska, A Place At Home is an established home care franchise network serving communities across the United... Read More »
PE Firm Ampersand Capital Partners Acquires Purna Pharmaceuticals

PE Firm Ampersand Capital Partners Acquires Purna Pharmaceuticals

On February 12, Massachusetts-headquartered Ampersand Capital Partners announced its acquisition of Purna Pharmaceuticals. Purna Pharmaceuticals is an independent Belgian company established in 1986. The company provides contract services for the development and manufacturing of semi-solid, powders and liquid pharmaceutical products that meet GXP standards as well as specific customer-related requirements. Founded in 1988, Ampersand is a middle-market private equity firm with more than $3 billion of assets under management dedicated to investments in the life sciences and healthcare sectors. As part of Ampersand’s broader life sciences portfolio, the investment creates opportunities for... Read More »
PE Firm Ampersand Capital Partners Acquires Purna Pharmaceuticals

Arcline Investment Management Sells Resolution Medical to Resonetics

Arcline Investment Management, a Nashville, Tennessee-based private equity firm, announced that it has entered into a definitive agreement to sell its portfolio company Resolution Medical to Resonetics. Based in Fridley, Minnesota, Resolution Medical is a scaled, end-to-end engineering services and outsourced manufacturing partner focused on complex Class II and III devices for medical technology markets including structural heart, cardiology and vascular, electrophysiology and neuromodulation therapies. With 240 employees, Resolution Medical provides expertise in device design, prototyping, bio-simulation and product design, through to finished device manufacturing. Founded in 1987,... Read More »
Life Sciences R&D M&A Market Overview: Strategic Buyers Amid a Cooling Market

Life Sciences R&D M&A Market Overview: Strategic Buyers Amid a Cooling Market

Despite a recent cooling in Life Sciences R&D, there has been a shift among buyers towards more selective, strategic acquisitions that prioritize quality over quantity. The Life Sciences R&D sector, encompassing clinical trial management, contract research organization (CRO) services and contract development and manufacturing organization (CDMO) capabilities, plays a central role in biopharmaceutical innovation. These providers help drug developers overcome steep costs, lengthy timelines and regulatory hurdles to deliver new therapies to patients. With biopharma companies under pressure to accelerate pipelines amid rising chronic disease burdens and aging populations, outsourcing... Read More »
The IMA Group Expands Clinical Research Division With Chicago Acquisition

The IMA Group Expands Clinical Research Division With Chicago Acquisition

The IMA Group announced on October 8 the acquisition of Chicago Research Center (CRC), an independent clinical research site based in Chicago, Illinois. Founded in 2005, CRC is known for its expertise in Phase I–IV trials, focused on the central nervous system, sleep disorders, mood and memory disorders, pain and general medicine. The company operates a research sleep lab for dedicated use in insomnia, apnea, narcolepsy, restless leg and shift work sleep disorder clinical trials. The IMA Group provides government workers with medical, psychological and related evaluations, as well as ancillary services, assists payers with case management and occupational health management solutions and... Read More »
ACL Digital Acquires New Jersey-based CRO Symbiance

ACL Digital Acquires New Jersey-based CRO Symbiance

San Jose, California-based ACL Digital has announced the acquisition of Princeton, New Jersey-based Symbiance. Financial terms were not disclosed.  Symbiance is a data-driven, technology-enabled contract research organization (CRO) with more than three decades of expertise in clinical data services and operations, medical monitoring, project management, medical writing and pharmacovigilance segments.  ACL Digital, an ALTEN Group company, is a leader in design-led digital transformation, product innovation and engineering services. The company serves clients across life sciences, telecom, media and technology sectors, delivering AI-powered, cloud-native and mobile-ready... Read More »
PE Firm Ampersand Capital Partners Acquires Purna Pharmaceuticals

TEAM Technologies Buys CDMO TAG3 Engineering

TEAM Technologies has announced the acquisition of TAG3 Engineering LLC. TAG3 brings expanded U.S.-based front-end innovation capabilities to TEAM Tech’s portfolio of specialty manufacturing solutions for the medical device industry.  TAG3 Engineering is a full-service MedTech design, development and manufacturing partner, dedicated to driving innovation in the development of medical devices. TAG3 Engineering partners with inventors, start-ups and medical device companies to accelerate the design and development of their medical devices. TAG3 is ISO 13485-certified and operates a fully equipped 16,000-square-foot facility for design, development and manufacturing in Sunrise,... Read More »